If your clinician has recommended injectable testosterone replacement therapy (TRT), you may have come across several different names: enanthate, Sustanon, Nebido, cypionate. They all deliver the same hormone, testosterone, but the chemical attachment on each one, called an ester, controls how quickly it is released into the bloodstream and therefore how often you need an injection. This guide explains what each one is, how they differ, which are actually licensed for use in the UK, and how a clinician decides which to prescribe.
Why there is more than one injectable testosterone
Pure testosterone injected on its own would be cleared from the body within hours, so every injectable product attaches a fatty acid chain, the ester, to the testosterone molecule. The ester slows the rate at which testosterone is released from the injection site into the blood. A shorter ester chain releases testosterone faster and wears off sooner, meaning more frequent injections; a longer ester chain releases it more slowly, allowing longer gaps between doses. This single difference, ester length, is what separates enanthate, Sustanon, Nebido and cypionate from one another, even though the active hormone is identical in each.
In the UK, the choice of injectable product is also shaped by licensing. Only certain testosterone esters hold a UK marketing authorisation, which affects what a UK-registered clinician can prescribe, regardless of what might be available or commonly used elsewhere, such as in the United States.
Testosterone enanthate: licensed in the UK
Testosterone enanthate is a single-ester injectable testosterone that is licensed for use in the UK. It is typically given by intramuscular injection every 2 to 3 weeks, which keeps levels within a workable range between doses while avoiding the cost and inconvenience of injecting more often.
Because it is a shorter-acting ester compared with Nebido, enanthate produces a noticeable peak in testosterone levels in the day or two after injection, followed by a gradual decline until the next dose is due. Some men notice this pattern as subtle shifts in energy, mood or libido across the injection cycle, though many do not find it troublesome once they settle into a routine. Enanthate is a well-established option with a long track record and is one of the more commonly prescribed injectable testosterones in UK private and NHS men's health services.
Many men on enanthate are taught to self-inject at home once a clinician has shown them the technique, rotating between the thigh and buttock to reduce soreness at the injection site. Rotating sites and sticking to the same spacing between doses, rather than letting the interval drift, helps keep levels more predictable between blood tests.
Sustanon 250: a blend of four esters
Sustanon 250 is a different approach to the same problem: instead of a single ester, it blends four testosterone esters of varying lengths in one injection. The shortest ester releases quickly, giving a faster initial rise in testosterone, while the longest ester continues releasing for longer, extending the tail of the dose. In practice this gives a smoother overall release profile than a single short ester alone, though Sustanon is usually dosed on a similar roughly 3-weekly schedule to enanthate.
Sustanon is licensed and widely used in the UK, and the choice between it and enanthate often comes down to clinician preference, product availability, and how an individual patient's levels and symptoms track on each one. Neither is clearly superior for every patient; the right one is usually found through a short period of monitoring and adjustment.
Nebido: the long-acting option
Nebido contains testosterone undecanoate, the longest-acting ester used in UK practice, dosed at 1000 mg per injection. The dosing schedule is distinctive: a first injection, a second at 6 weeks to establish steady levels, then subsequent injections every 10 to 14 weeks once the dosing interval is stable.
Because doses are spaced so far apart, Nebido gives notably steadier testosterone levels over time than shorter-acting esters, with far fewer peaks and troughs. The trade-off is that each injection delivers a large dose that cannot be quickly reversed if it does not suit you, and loading takes longer to settle into its regular rhythm. For men who dislike frequent injections, or whose levels fluctuate uncomfortably on shorter-acting products, Nebido is often a welcome change once the initial loading phase is complete.
Testosterone cypionate: common in the US, not licensed in the UK
Testosterone cypionate is the most widely prescribed injectable testosterone in the United States, where it plays a similar role to enanthate in UK practice: a single-ester product typically injected every 1 to 2 weeks. Pharmacologically, cypionate behaves very similarly to enanthate, with a comparable release profile and injection frequency.
The key difference for UK patients is regulatory, not pharmacological: testosterone cypionate is not a UK-licensed product, so it is not something a UK-registered clinician can prescribe through normal NHS or private pathways. Men who have previously used cypionate abroad, or who have come across it online, should be aware that a UK clinician will instead offer enanthate, Sustanon or Nebido, which achieve a comparable clinical effect using testosterone esters that do hold a UK licence. Sourcing cypionate, or any testosterone product, outside a regulated UK prescribing pathway is unsafe and is not equivalent to clinician-led treatment.
How clinicians choose between them
With several UK-licensed options available, the choice between testosterone enanthate, Sustanon 250 and Nebido usually comes down to a handful of practical factors rather than one product being universally better.
- Injection frequency tolerance. Some men prefer injecting every 2 to 3 weeks and adjusting more frequently; others would rather inject a handful of times a year with Nebido.
- Sensitivity to fluctuating levels. Men who notice mood, energy or libido dips as a dose wears off may do better on the steadier profile Nebido provides.
- Starting point and loading. Nebido's loading schedule takes longer to settle, which matters if a clinician wants to see how you respond and adjust more quickly at the start of treatment.
- Clinical judgement and monitoring. Your prescribing clinician will weigh your blood results, symptoms and any other health conditions, such as cardiovascular risk factors or a raised red blood cell count, which can influence which formulation and dosing interval is appropriate.
Cost and supply can also play a role: product availability varies slightly between pharmacies and clinics, and some men find one injection schedule simply fits their lifestyle, travel or work pattern better than another. None of these practical factors override clinical suitability, but once a product is confirmed to be medically appropriate, they often tip the final decision.
All injectable testosterone in the UK is prescription-only and must be dispensed by a GPhC-registered pharmacy, with regular monitoring built into treatment regardless of which product you use. Switching between products is possible if your first choice does not suit you, but your dose and monitoring schedule will usually need reassessing afterwards, since the esters are not interchangeable milligram for milligram. If you are weighing up injections against other formulations, our guide to testosterone gel for TRT covers the daily-application alternative, and our overview of testosterone replacement therapy sets out the full UK diagnostic pathway and monitoring plan. Before changing anything about an existing prescription, speak to your prescribing clinician rather than adjusting the dose or product yourself.